4//SEC Filing
USMAN NASSIM 4
Accession 0001140361-23-050616
CIK 0001124105other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 6:15 AM ET
Size
7.1 KB
Accession
0001140361-23-050616
Insider Transaction Report
Form 4
USMAN NASSIM
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-10-31+341,652→ 341,652 totalExercise: $6.93Exp: 2033-10-31→ Common Stock (341,652 underlying) - Award
Stock Option (Right to Buy)
2023-10-31+1,866→ 1,866 totalExercise: $6.93Exp: 2033-10-31→ Common Stock (1,866 underlying)
Footnotes (2)
- [F1]These options are vested in full.
- [F2]These options vest as to one-third on each of the first, second and third anniversaries of October 31, 2023, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
GYRE THERAPEUTICS, INC.
CIK 0001124105
Entity typeother
Related Parties
1- filerCIK 0001206872
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 6:15 AM ET
- Size
- 7.1 KB